Arcoxia (etoricoxib)-Important Safety Information from Merck Sharp & Dohme following approval by the IMB
30 September 2008
Please find herewith an important safety communication from Merch Sharp & Dohme regarding the risk of hypertension-related adverse events associated with the use of etoricoxib, and of the contraindication for use in patients with hypertension whose blood pressure is not adequately controlled.
Arcoxia 30mg film coated tablet
Arcoxia 60mg film coated tablet
Arcoxia 90mg film coated tablet
Arcoxia 120mg film coated tablet